1. HBW Insight
  2. >>Health
  3. >>Innovation & IP
  4. >>Trademarks

Health And Wellness Weekly Trademarks Review: 9 January

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

• Source: Alamy

Trademarks Class 3 include cosmetics and cleaning preps and class 5 includes pharmaceuticals. Marks for vitamin, mineral and supplement products also are registered or published for opposition in both Class 3 and Class 5. The list of Class 3 and Class 5 entries from the 9 January issue of the Official Gazette is linked below in a downloadable and searchable PDF.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Trademarks

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Health And Wellness Weekly Trademarks Review: 9 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Health And Wellness Weekly Trademarks Review: 2 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Health And Wellness Weekly Trademarks Review: 26 March

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

More from Innovation & IP

Over The Counter: Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell

 
• By David Ridley

HBW Insight catches up with Maxwellia CEO Anna Maxwell to discuss her company's journey so far, and what she sees as the opportunities for Rx-to-OTC switch in UK women's health and beyond.

Haleon Launches ‘Prescription Strength’ Hayfever Remedy In The UK

 
• By David Ridley

Pirilieve Hayfever Relief Tablets contain 120mg fexofenadine hydrochloride, which the firm notes is an active ingredient that was “previously only available behind pharmacy counters.”

Haleon’s US Eroxon Launch Falls Short Of Expectations

 
• By Tom Gallen

Consumer uptake of Eroxon - the first FDA-approved OTC ED treatment available in the US - has been slower than expected, according to Haleon, which says its working with retailers to build awareness.